Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779616) titled 'Study of PTC844 in Participants With Active Rheumatoid Arthritis' on Aug. 18.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: PTC Therapeutics

Condition: Rheumatoid Arthritis

Intervention: Drug: PTC844

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: August 31, 2026

Target Sample Size: 75

To know more, visit https://clinicaltrials.gov/study/NCT07779616

Disclaimer: Curated by HT Syndication....